Short-term and Long-term Success of Electrical Cardioversion in Atrial Fibrillation in Managed Care System

Overview

Journal Int Arch Med

Publisher iMedPub

Specialty General Medicine

Date 2009 Dec 17

PMID 20003371

Citations 13

Authors

Suman S Kuppahally

Elyse Foster

Stanford Shoor

Anthony E Steimle

Affiliations

Soon will be listed here.

Abstract

Background: Initial success of electrical cardioversion (ECV) of atrial fibrillation (AF) has been reported in several studies as 50%-90%, of which only 50% patients remain in sinus rhythm (SR) at the end of one year. We conducted this study to see if outcomes of other trials are applicable in managed care setting.

Methods: We conducted a retrospective study in 370 consecutive patients who underwent ECV for AF. They were reviewed for initial outcome of ECV and recurrence of AF after a successful ECV, with and without prophylactic antiarrhythmic drugs.

Results: Initial success of ECV for AF was 65.7%. At one year, 47% remained in SR. AF for </= 3 months (p = 0.006) and pretreatment with antiarrhythmic drugs (p = 0.032) resulted in improved success. Predictors of recurrence were patients </= 65 years (p = 0.019), paroxysmal atrial fibrillation (PAF) (p = 0.0094) and alcohol consumption (p = 0.0074).

Conclusion: Shorter duration of AF, prophylactic antiarrhythmic drugs and serial ECVs improve outcome of ECV in AF. For younger patients with PAF and alcohol consumption, due to higher recurrence of AF, rate control or ablative therapy may be the preferred strategy.

Citing Articles

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation.

Antoun I, Li X, Kotb A, Barker J, Mavilakandy A, Koev I Front Cardiovasc Med. 2024; 11:1417029.

PMID: 39119182 PMC: 11306046. DOI: 10.3389/fcvm.2024.1417029.

Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital.

Okhotin A, Osipov M, Osipov V, Barchuk A BMC Cardiovasc Disord. 2024; 24(1):213.

PMID: 38632510 PMC: 11022487. DOI: 10.1186/s12872-024-03885-0.

Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis.

Nguyen S, Belley-Cote E, Ibrahim O, Um K, Lengyel A, Adli T Europace. 2022; 25(2):318-330.

PMID: 36503970 PMC: 9935008. DOI: 10.1093/europace/euac199.

Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study.

Teppo K, Jaakkola J, Biancari F, Halminen O, Putaala J, Mustonen P BMJ Open. 2022; 12(8):e059759.

PMID: 36041755 PMC: 9438075. DOI: 10.1136/bmjopen-2021-059759.

Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model.

Nunez-Garcia J, Sanchez-Puente A, Sampedro-Gomez J, Vicente-Palacios V, Jimenez-Navarro M, Oterino-Manzanas A J Clin Med. 2022; 11(9).

PMID: 35566761 PMC: 9101912. DOI: 10.3390/jcm11092636.

References

Pritchett E . Management of atrial fibrillation. N Engl J Med. 1992; 326(19):1264-71. DOI: 10.1056/NEJM199205073261906. View

Coplen S, Antman E, Berlin J, Hewitt P, CHALMERS T . Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990; 82(4):1106-16. DOI: 10.1161/01.cir.82.4.1106. View

Oral H, Souza J, Michaud G, Knight B, Goyal R, Strickberger S . Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999; 340(24):1849-54. DOI: 10.1056/NEJM199906173402401. View

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg M, Green M . Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000; 342(13):913-20. DOI: 10.1056/NEJM200003303421302. View

Ausma J, WIJFFELS M, Thone F, Wouters L, Allessie M, Borgers M . Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997; 96(9):3157-63. DOI: 10.1161/01.cir.96.9.3157. View

Olshansky B, Heller E, Mitchell L, Chandler M, Slater W, Green M . Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol. 2005; 45(12):2026-33. DOI: 10.1016/j.jacc.2005.03.020. View

Therkelsen S, Groenning B, Svendsen J, Jensen G . Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol. 2006; 97(8):1213-9. DOI: 10.1016/j.amjcard.2005.11.040. View

Van Gelder I, Hagens V, Bosker H, Kingma J, Kamp O, Kingma T . A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002; 347(23):1834-40. DOI: 10.1056/NEJMoa021375. View

Sabatini T, Frisoni G, Barbisoni P, Bellelli G, Rozzini R, Trabucchi M . Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc. 2000; 48(4):387-90. DOI: 10.1111/j.1532-5415.2000.tb04695.x. View

10.

van Gelder I, Crijns H, van Gilst W, Verwer R, Lie K . Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991; 68(1):41-6. DOI: 10.1016/0002-9149(91)90707-r. View

11.

Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G . Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004; 90(4):400-5. PMC: 1768173. DOI: 10.1136/hrt.2003.015347. View

12.

Chen J, Hoff P, Erga K, Rossvoll O, Ohm O . A clinical study of patients with and without recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation. Pacing Clin Electrophysiol. 2005; 28 Suppl 1:S86-9. DOI: 10.1111/j.1540-8159.2005.00021.x. View

13.

van Gelder I, Crijns H, Tieleman R, Brugemann J, de Kam P, Gosselink A . Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996; 156(22):2585-92. DOI: 10.1001/archinte.156.22.2585. View

14.

Israel C, Gronefeld G, Ehrlich J, Li Y, Hohnloser S . Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004; 43(1):47-52. DOI: 10.1016/j.jacc.2003.08.027. View

15.

Carlsson J, Tebbe U, Rox J, HARMJANZ D, Haerten K, Neuhaus K . Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. Am J Cardiol. 1996; 78(12):1380-4. DOI: 10.1016/s0002-9149(96)00647-9. View

16.

Gonzalez M . Rate control vs. pulmonary vein isolation. Am J Geriatr Cardiol. 2005; 14(1):26-30. DOI: 10.1111/j.1076-7460.2005.03340.x. View

17.

Suttorp M, Kingma J, Koomen E, van t Hof A, Tijssen J, Lie K . Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol. 1993; 71(8):710-3. DOI: 10.1016/0002-9149(93)91015-a. View

18.

Khargi K, Hutten B, Lemke B, Deneke T . Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005; 27(2):258-65. DOI: 10.1016/j.ejcts.2004.11.003. View

19.

Djousse L, Levy D, Benjamin E, Blease S, Russ A, Larson M . Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004; 93(6):710-3. DOI: 10.1016/j.amjcard.2003.12.004. View

20.

Fuster V, Ryden L, Cannom D, Crijns H, Curtis A, Ellenbogen K . ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of.... J Am Coll Cardiol. 2006; 48(4):854-906. DOI: 10.1016/j.jacc.2006.07.009. View